ferric maltol · Shield Tx · NDA 212320
Accrufer
Earliest generic entry, as listed
23 Oct 2035
Blocked by patent: US 9802973.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9802973 | drug substance, drug product, use U-2603 · sets the listed date | 23 Oct 2035 |
| US 10179120 | use U-2603 | 6 Jan 2035 |
| US 9248148 | use U-2603 | 29 Mar 2031 |
Exclusivities · 1 unexpired
| NPP | new patient population | 19 Dec 2028 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 212320 · 001 · RLD | capsule, oral | 30MG IRON | 23 Oct 2035 |